Skip to content
x.com· @ · X·· 2026-04-22Score60
Body

#AACR26 🎤 drop.

Unveiling our first results @AACR—CLOVER ☘️ trial enrollment is COMPLETE.

6️⃣0️⃣/6️⃣0️⃣ 💯% started treatment.

Record-pace accrual. Grateful to our patients, caregivers, study teams, & sponsor.

Important milestone!

🔗 🗞️ 👏🏽 @OncoAlert

https://t.co/ktqqWCNuc8 https://t.co/VO8fiwhKpX

Heat 42 · 32 likes · 2 replies · 8 reposts

Source: x.com · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org